CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-20 | LYONS GARY A Director | Grant or award | +25,000 | 50,000 | ||
| 2022-05-20 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-05-20 | HANNAH ALISON L. Director | Grant or award | +25,000 | 31,250 | ||
| 2022-05-20 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-05-20 | Ali-Jackson Kamil Director | Grant or award | +18,750 | 18,750 | ||
| 2022-05-20 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2022-05-20 | Kotzin Brian L. Director | Grant or award | +25,000 | 50,000 | ||
| 2022-05-20 | Kotzin Brian L. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-01-24 | Schorno Dean L EVP &Chief Financial Officer | Grant or award | +50,000 | 128,908 | ||
| 2022-01-24 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-24 | Dummer Wolfgang EVP & CMO | Grant or award | +50,000 | 67,848 | ||
| 2022-01-24 | Dummer Wolfgang EVP & CMO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-24 | Santos David A EVP, Chief Commercial Officer | Grant or award | +50,000 | 60,000 | ||
| 2022-01-24 | Santos David A EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-01-24 | RODRIGUEZ RAUL R CEO, President | Grant or award | +200,000 | 391,776 | ||
| 2022-01-24 | RODRIGUEZ RAUL R CEO, President | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2022-01-24 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award | +50,000 | 60,260 | ||
| 2022-01-24 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-12-16 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-11-04 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +81,250 | 81,250 |
Page 11 of 16 · 310 trades